Clinical Investigation

Kidney International (1986) 29, 1215–1223; doi:10.1038/ki.1986.130

Adult–onset minimal change nephrotic syndrome: A long–term follow–up

Fernando Nolasco1, J Stewart Cameron1, E F Heywood1, Jackie Hicks1, Chisholm Ogg1 and D Gwyn Williams1

1Renal Unit, Guy's Hospital Medical School, London, United Kingdom

Correspondence: Professor J S Cameron, Clinical Science Laboratories, 17th Floor, Guy's Tower, Guy's Hospital, London, SE1 9RT United Kingdom

Received 18 July 1985; Revised 11 November 1985.

Top

Abstract

Adult–onset minimal change nephrotic syndrome: a long–term follow–up. A series of 89 adult–onset nephrotic patients with minimal changes on renal biopsy was analyzed to compare the rate of response to corticosteroids and cytotoxic agents and the stability of remission or frequency of relapses at different ages. Severe hypertension and diminished renal function were more common in patients aged over 60 years, who formed 22.5% of the group. Seventy–five patients were given a first course of prednisolone in an initial dose of 60 mg/24 hr. After an eight week course of tapering doses of corticosteroids, only 45 of the 75 patients were in complete remission, 55 patients after 16 weeks and eventually 58 lost their proteinuria. The respective estimates of remission were 60%, 76% and 81%. Subsequently, of the 58 treated patients who responded, 24% never relapsed. Fifty–six percent of the patients relapsed on a single occasion or infrequently, and only 21% were frequent relapsers. Cyclophosphamide was used in 36 patients, in two as initial treatment, in 11 because of corticosteroid resistance, and in the remainder because of relapses. The time–course of loss of proteinuria was similar to that following treatment with corticosteroids, 25 (69%) losing proteinuria within 16 weeks. Only four patients failed to lose their nephrotic syndrome. Two of them had presented in acute renal failure and all four were over 60 years of age. The stability of remission after cyclophosphamide was better than that reported for children, only 13 of 36 showing relapses and 66% being in remission at five years, after which no further relapses were seen. Of the whole group (89), at the most recent follow–up, only 13 patients still had active disease and only five were nephrotic (6%). Mortality was confined to older patients; only 5 of 15 deaths were the result of complications of the nephrotic syndrome, and the rest incidental. Thus, although adults with a minimal change nephrotic syndrome resemble children with this condition in many respects, they go into acute renal failure more frequently, have hypertension or diminished renal function more often, respond more slowly and slightly less often to both corticosteroids and cytotoxic agents, but relapse less frequently and have more stable remissions after cyclophosphamide treatment.

Top

References

  1. International Study of Kidney Disease in Children: Prediction of histopathology from clinical and laboratory characteristics at the time of diagnosis. Kidney Int 13:159–165, 1978
  2. International Study of Kidney Disease in Children: Pathology of the nephrotic syndrome in children. Lancet 1:1299–1302, 1970
  3. International Study of Kidney Disease in Children: The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. J Pediatr 98:560–564, 1981
  4. International Study of Kidney Disease in Children: Prospective, controlled trial of cyclophosphamide therapy in children with the nephrotic syndrome. Lancet 2:423–427, 1974
  5. International Study of Kidney Disease in Children: A randomized trial comparing two prednisone regimens in steroid–responsive patients who relapse early. J Pediatr 95:239–243, 1979
  6. Siegel NJ, Goldberg B, Krassner LS, Hayslett JP: Long term follow–up of children with steroid–responsive nephrotic syndrome. J Pediatr 81:251–258, 1972
  7. Koskimies O, Vilska J, Rapola J, Hallman N: Long term of outcome of primary nephrotic syndrome. Arch Dis Child 57:544–548, 1982 | PubMed | ISI | ChemPort |
  8. Trompeter RS, Lloyd BW, Hicks J, White RHR, Cameron JS: Long term follow-up of unselected children with biopsy–proven minimal change nephrotic syndrome (MCNS). (abstract) Europ J Pediatr 140:170, 1983
  9. Siegel NF, Gaudi KM, Krassner LS, McDonald BM, Anderson FP, Kashgarian M: Steroid dependent nephrotic syndrome in children: histopathology and relapse after cyclophosphamide treatment. Kidney Int 19:454–459, 1981 | PubMed | ISI | ChemPort |
  10. Arbeitsgemeinschaft für Pädiatrishe Nephrologie: Effect of cytotoxic drugs in frequency relapsing nephrotic syndrome with and without steroid dependence. N Engl J Med 306:451–454, 1982
  11. Garin EH, Pryor ND, Fennell RS, Richard GA: Pattern of response to prednisone in idiopathic minimal lesion nephrotic syndrome as a criterion in selecting patients for cyclophosphamide therapy. J Pediatr 92:304–308, 1978
  12. Cameron JS, Chantler C, Ogg CS, White RHR: Long term stability of remission in nephrotic syndrome after treatment with cyclophosphamide. Br Med J 4:7–11, 1974
  13. Williams SA, Makker SP, Ingelfinger JR, Grupe WE: Long term evaluation of chlorambucil plus prednisone in the idiopathic nephrotic syndrome of childhood. N Engl J Med 302:929–933, 1980 | PubMed | ISI | ChemPort |
  14. Grupe WE, Makker SP, Ingelfinger JR: Chlorambucil treatment of frequently–relapsing nephrotic syndrome. N Engl J Med 295:746–749, 1976 | PubMed | ISI | ChemPort |
  15. Callis L, Nieto J, Vila A, Rende J: Chlorambucil treatment in minimal lesion nephrotic syndrome: a reappraisal of its gonadal toxicity. J Pediatr 97:653–656, 1983
  16. Kleinknecht C, Gubler MC, Gagnadou MF, Broyer M: Chronic renal failure (CRF) in children with steroid responsive nephrosis (SRN): Report of 8 cases. (abstract) Europ J Pediatr 150:190, 1983
  17. Trainin EB, Gomez–Leon G: Development of renal insufficiency after long standing steroid–responsive nephrotic syndrome. Int J Pediatr Nephrol 3:56–58, 1982
  18. Nash MA, Bakara MA, D'Agate V, Pirani CL: Late development of chronic renal failure in steroid–responsive nephrotic syndrome. J Pediatr 101:411–414, 1982
  19. Coggins CH: Minimal change nephrosis in adults, in Proceedings of the 8th International Congress of Nephrology, edited by Zurukzoglu W, Basel, Karger 1981 pp 336–344
  20. Sharpstone P, Ogg CS, Cameron JS: Nephrotic syndrome due to primary renal disease in adults: A Survey of Incidence in South–East England. Br Med J 2:533–535, 1969
  21. Cameron JS, Turner DR, Ogg CS, Sharpstone P, Brown CB: The nephrotic syndrome in adults with 'minimal change' nephrotic glomerular lesions. Q J Med 171:461–468, 1974
  22. Lim VS, Sibley R, Spargo B: Adult lipoid nephrosis: clinicopathological correlations. Ann Intern Med 81:314–320, 1974 | PubMed | ISI | ChemPort |
  23. Bolton WK, Atuk NO, Sturgill BC, Westervelt FB: Therapy of the idiopathic nephrotic syndrome with alternate day steroids. Am J Med 62:60–70, 1977 | Article | PubMed | ISI | ChemPort |
  24. Hopper J, Ryan P, Lee JJC, Rosenau W: Lipoid nephrosis in 31 adult patients: renal biopsy study by light, electron and fluorescence microscopy with experience in treatment. Medicine (Baltimore) 49:321–341, 1970
  25. Hlatky MA: Is renal biopsy necessary in adults with nephrotic syndrome? Lancet 2:1264–1268, 1982
  26. Kassirer J: Is renal biopsy necessary for optimal management of the idiopathic nephrotic syndrome? Kidney Int 24:561–575, 1983
  27. Vilches AR, Turner DR, Cameron JS, Ogg CS, Chantler C, Williams DG: Significance of IgM deposition in 'minimal change' nephrotic syndrome. Lab Invest 46:10–15, 1982
  28. Chantler C, Garnett ES, Parsons V, Veall N: Glomerular filtration rate measurement in man by the single injection method using 51Cr EDTA. Clin Sci 37:169–180, 1969 | PubMed | ISI | ChemPort |
  29. Moorthy AV, Zimmerman SW: Renal disease in the elderly: clinicopathological analysis of renal disease in 115 elderly patients. Clin Nephrol 14:223–229, 1980 | PubMed |
  30. Zech P, Colon S, Pointet PH, Deteix P, Labeeux M, Leitienne PG: The nephrotic syndrome in adults aged over 60—etiology of 76 cases. Clin Nephrol 17:232–236, 1982 | PubMed | ISI | ChemPort |
  31. Cohen AH, Border WA, Glassock RJ: Nephrotic syndrome with glomerular mesangial IgM deposits. Lab Invest 38:610–619, 1978 | PubMed | ISI | ChemPort |
  32. Habib R, Kleinknechy C, Royer P: The primary nephrotic syndrome of childhood: classification and clinicopathologic study of 406 cases, in Pathology Annual, edited by Sommers SC, Appleton, New York, Century Crofts, 1971 pp. 417–474
  33. White RHR, Glasgow EF, Mills RJ: Clinicopathologic study of nephrotic syndrome in childhood. Lancet 1:1353–1359, 1970 | PubMed | ISI | ChemPort |
  34. Nolasco F, Cameron JS, Ogg CS, Hartley B, Neild GH, Taube D, Williams DG: Acute renal failure requiring dialysis in adult patients with a nephrotic syndrome (NS) and minor glomerular lesions. (abstract) 20th Congress of the EDTA-ERA, London, 1983, p. 96
  35. Steele BT, Bacheyie GS, Baumal R, Rance CPH: Acute renal failure of short duration in minimal lesion nephrotic syndrome of childhood. Int J Pediatr Nephrol 3:59–62, 1982
  36. Georgaki H, Cameron JS, Chantler C, Haycock GH: Established acute renal failure in nephrotic children. (abstract) Europ J Pediatr 140:209, 1983
  37. Black DAK, Rose G, Brewer DB: A controlled trial of prednisone in adults with the nephrotic syndrome. Br Med J 3:421–426, 1970 | PubMed |
  38. Barnett H, Schoenman M, Bernstein J, Edelmann CM: Minimal change nephrotic syndrome, in Pediatric Nephrology, edited by Edelmann CM, Boston, Little Brown, 1978, pp. 695–711
  39. Schwartz MW, Schwartz GJ, Cornfield D: A 16 year follow–up of 163 children with nephrotic syndrome. Pediatrics 54:547–552, 1974
  40. Barratt TM, Soothill JF: Controlled trial of cyclophosphamide in steroid–sensitive relapsing nephrotic syndrome of childhood. Lancet 2:479–482, 1970 | PubMed | ISI | ChemPort |
  41. Grupe WE: Relapsing nephrotic syndrome in childhood. Kidney Int 16:75–85, 1979
  42. Raij L, Keane WF, Leonard A, Shapiro FL: Irreversible acute renal failure in idiopathic nephrotic syndrome. Am J Med 61:207–214, 1976 | Article | PubMed | ISI | ChemPort |
  43. Lowenstein J, Schacht RG, Baldwin DS: Renal failure in minimal change nephrotic syndrome. Am J Med 70:227–233, 1981 | Article | PubMed | ISI | ChemPort |
  44. Cameron JS, Ogg CS, Wass V: Complications of the nephrotic syndrome, in The nephrotic syndrome, edited by Cameron JS, Glassock RJ, New York, Marcel Dekker, (in press)
  45. Cameron JS: Coagulation and Thrombotic complications in the nephrotic syndrome. Adv Nephrol 13:137–173, 1983
  46. Wass V, Cameron JS: Cardiovascular disease and the nephrotic syndrome; the other side of the coin. Nephron 27:58–61, 1981
  47. Kinlen LJ, Sheil AGR, Peto J, Doll R: Collaborative United Kingdom–Australasian Study of cancer in patients treated with immunosuppressive drugs. Br Med J 2:1461–1466, 1979 | PubMed | ISI | ChemPort |
  48. Trompeter RS, Evans PR, Barratt TM: Gonadal function in boys with steroid responsive nephrotic syndrome treated with cyclophosphamide. Lancet 1:1177–1179, 1981 | PubMed | ChemPort |
  49. Al-Khader AA, Lien JWK, Aber GM: Cyclophosphamide alone in the treatment of adult patients with minimal change glomerulonephritis. Clin Nephrol 11:26–30, 1979 | PubMed | ChemPort |
  50. International Study of Kidney Disease in Children: Primary nephrotic syndrome in children: clinical significant of histopathologic variants of minimal change and of diffuse mesangial hypercellularity. Kidney Int 20:765–771, 1981
  51. Peto R, Pike MC, Armitage M, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG: Design and analysis of randomized trials requiring prolonged observation of each patients. II. Analysis and examples. Brit J Cancer 35:1–38, 1977

Extra navigation

.
ADVERTISEMENT